Literature DB >> 3820369

Impact of routine screening for adenocarcinoma of the prostate on stage distribution.

I M Thompson, J B Rounder, J L Teague, M Peek, C R Spence.   

Abstract

The impact of routine screening with digital rectal examination for carcinoma of the prostate on stage distribution of the disease was assessed in the primary treatment population of our medical center. Two, 5-year periods were compared: 1974 to 1978--before the onset of routine screening and 1979 to 1983--during the period of routine screening of this population. The clinical stage distribution of prostatic cancer before the onset of routine screening was not significantly different from national averages. Routine screening during the latter period significantly increased the percentage of patients with clinically curable carcinoma of the prostate. Pathologically, the disease was upstaged in many patients in both series. Digital rectal examination can have a significant impact on early detection of carcinoma of the prostate within a given population but it cannot be interpreted as a panacea for this disease.

Entities:  

Mesh:

Year:  1987        PMID: 3820369     DOI: 10.1016/s0022-5347(17)44055-9

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  10 in total

1.  Is digital screening for prostatic cancer effective?

Authors:  D B Louria
Journal:  Bull N Y Acad Med       Date:  1992-11

2.  Is deleting the digital rectal examination a good idea?

Authors:  M A Sutton; R P Gibbons; R J Correa
Journal:  West J Med       Date:  1991-07

Review 3.  Periodic health examination, 1991 update: 3. Secondary prevention of prostate cancer. Canadian Task Force on the Periodic Health Examination.

Authors: 
Journal:  CMAJ       Date:  1991-09-01       Impact factor: 8.262

4.  Screening for carcinoma of the prostate.

Authors:  D Chadwick; D A Gillatt; J C Gingell; P H Abrams
Journal:  BMJ       Date:  1990-07-14

Review 5.  Screening for prostate cancer. Implications for drug therapy.

Authors:  R H Harwood
Journal:  Drugs Aging       Date:  1995-05       Impact factor: 3.923

6.  Screening for prostate cancer. How can patients give informed consent?

Authors:  K G Marshall
Journal:  Can Fam Physician       Date:  1993-11       Impact factor: 3.275

7.  Screening for prostate cancer in Romania.

Authors:  Raphaela Waidelich; Gheorghe Bumbu; Marius Raica; Marieta Toma; Teodor Maghiar; Alfons Hofstetter
Journal:  Int Urol Nephrol       Date:  2002       Impact factor: 2.370

8.  Prostate cancer: trends in mortality and stage-specific incidence rates by racial/ethnic group in Los Angeles County, California (United States).

Authors:  K L Danley; J L Richardson; L Bernstein; B Langholz; R K Ross
Journal:  Cancer Causes Control       Date:  1995-11       Impact factor: 2.506

Review 9.  Screening for carcinoma of the prostate: efficacy of available screening tests.

Authors:  I M Thompson; W R Fair
Journal:  World J Surg       Date:  1989 Jan-Feb       Impact factor: 3.352

Review 10.  Progress and problems in screening for carcinoma of the prostate.

Authors:  G W Chodak; H W Schoenberg
Journal:  World J Surg       Date:  1989 Jan-Feb       Impact factor: 3.352

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.